{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:52:22Z","timestamp":1789912342828,"version":"4.0.1"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0039911","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T21:40:38Z","timestamp":1341006038000},"page":"e39911","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["A FRET-Based High Throughput Screening Assay to Identify Inhibitors of Anthrax Protective Antigen Binding to Capillary Morphogenesis Gene 2 Protein"],"prefix":"10.1371","volume":"7","author":[{"given":"Michael S.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna M.","family":"Cryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiane A.","family":"Habeshian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Bazinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Christine","family":"Ackroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.2432664","article-title":"Angiogenic factors.","volume":"235","author":"J Folkman","year":"1987","journal-title":"Science"},{"key":"ref2","first-page":"738","article-title":"Cell turnover of capillaries.","volume":"17","author":"RL Engerman","year":"1967","journal-title":"Lab Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jez.1402510210","article-title":"Vasculogenesis and angiogenesis: Two distinct morphogenetic mechanisms establish embryonic vascular pattern.","volume":"251","author":"TJ Poole","year":"1989","journal-title":"J Exp Zool"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1096\/fasebj.6.3.1371260","article-title":"Angiogenesis in the female reproductive system.","volume":"6","author":"LP Reynolds","year":"1992","journal-title":"Faseb J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: An organizing principle for drug discovery?","volume":"6","author":"J Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-82-1-96","article-title":"Tumor angiogenesis: A possible control point in tumor growth.","volume":"82","author":"J Folkman","year":"1975","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/339058a0","article-title":"Induction of angiogenesis during the transition from hyperplasia to neoplasia.","volume":"339","author":"J Folkman","year":"1989","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.yexcr.2005.10.021","article-title":"The effect of genetic diversity on angiogenesis.","volume":"312","author":"MS Rogers","year":"2006","journal-title":"Exp Cell Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0161-6420(95)30875-5","article-title":"Angiogenesis inhibition in age-related macular degeneration.","volume":"102","author":"R D'Amato","year":"1995","journal-title":"Ophthalmology"},{"key":"ref10","first-page":"137","article-title":"The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease.","volume":"68","author":"IC Michaelson","year":"1948","journal-title":"Trans Ophthalmol Soc U K"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1009071601454","article-title":"Angiogenesis and ophthalmic disease.","volume":"3","author":"AP Adamis","year":"1999","journal-title":"Angiogenesis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma.","volume":"341","author":"S Singhal","year":"1999","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"ES Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.","volume":"350","author":"H Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"PJ Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1158\/0008-5472.CAN-07-0829","article-title":"Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.","volume":"67","author":"MS Rogers","year":"2007","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/IAI.63.1.82-87.1995","article-title":"Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.","volume":"63","author":"VM Gordon","year":"1995","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin.","volume":"414","author":"KA Bradley","year":"2001","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.","volume":"100","author":"HM Scobie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium.","volume":"289","author":"B St Croix","year":"2000","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00001622-200401000-00009","article-title":"Tumor endothelial markers: New targets for cancer therapy.","volume":"16","author":"A Nanda","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"ref22","first-page":"1311","article-title":"Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.","volume":"29","author":"G Davies","year":"2006","journal-title":"Int J Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1158\/0008-5472.CAN-09-1086","article-title":"Host-derived tumor endothelial marker 8 promotes the growth of melanoma.","volume":"69","author":"M Cullen","year":"2009","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0748-7983(04)00212-4","article-title":"Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.","volume":"30","author":"KA Rmali","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3748\/wjg.v11.i9.1283","article-title":"Prognostic values of tumor endothelial markers in patients with colorectal cancer.","volume":"11","author":"KA Rmali","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbrc.2005.06.085","article-title":"TEM-8 and tubule formation in endothelial cells, its potential role of its vW\/TM domains.","volume":"334","author":"KA Rmali","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","article-title":"TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).","volume":"64","author":"A Nanda","year":"2004","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23227","DOI":"10.1074\/jbc.M603676200","article-title":"Anthrax toxin receptor 1\/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton.","volume":"281","author":"E Werner","year":"2006","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ccr.2012.01.004","article-title":"TEM8\/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types.","volume":"21(2)","author":"A Chaudhary","year":"2012","journal-title":"Cancer Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1242\/jcs.114.15.2755","article-title":"Differential gene expression during capillary morphogenesis in 3D collagen matrices: Regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.","volume":"114","author":"SE Bell","year":"2001","journal-title":"J Cell Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/onc.2009.383","article-title":"Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis.","volume":"29","author":"CV Reeves","year":"2010","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/378781","article-title":"Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.","volume":"73","author":"O Dowling","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1073\/pnas.0905409106","article-title":"Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.","volume":"106","author":"S Liu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e34862","DOI":"10.1371\/journal.pone.0034862","article-title":"Anthrax toxin receptor 2 functions in ECM homeostasis of the murine reproductive tract and promotes MMP activity.","volume":"7(4)","author":"CV Reeves","year":"2012","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2012.04.160","article-title":"Capillary morphogenesis protein-2 is required for mouse parturition by maintaining uterine collagen homeostasis.","author":"DE Peters","year":"2012"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1462-5822.2003.00253.x","article-title":"Anthrax toxins and the host: A story of intimacy.","volume":"5","author":"M Mock","year":"2003","journal-title":"Cell Microbiol"},{"key":"ref37","first-page":"7045","article-title":"The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.","author":"J Mogridge","year":"2002"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","article-title":"Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.","volume":"160","author":"L Abrami","year":"2003","journal-title":"J Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin.","volume":"19","author":"RJ Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M210321200","article-title":"Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.","volume":"278","author":"S Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"15737","DOI":"10.1021\/bi981436i","article-title":"Characterization of membrane translocation by anthrax protective antigen.","volume":"37","author":"J Wesche","year":"1998","journal-title":"Biochemistry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nbt1001-958","article-title":"Designing a polyvalent inhibitor of anthrax toxin.","volume":"19","author":"M Mourez","year":"2001","journal-title":"Nat Biotechnol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1126\/science.109563","article-title":"Dominant-negative mutants of a toxin subunit: An approach to therapy of anthrax.","volume":"292","author":"BR Sellman","year":"2001","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0928-8244(03)00302-X","article-title":"Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of bacillus anthracis.","volume":"40","author":"VA Karginov","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/IAI.73.6.3408-3414.2005","article-title":"Combining anthrax vaccine and therapy: A dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.","volume":"73","author":"BA Aulinger","year":"2005","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1086\/427189","article-title":"Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.","volume":"191","author":"X Cui","year":"2005","journal-title":"J Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1462-5822.2005.00606.x","article-title":"Inhibition of mitogen-activated protein kinase signalling by bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA.","volume":"8","author":"S Batty","year":"2006","journal-title":"Cell Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11064-006-9082-2","article-title":"Treatment and prophylaxis of anthrax by new neurosecretory cytokines.","volume":"31","author":"AA Galoyan","year":"2006","journal-title":"Neurochem Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1574-695X.2006.00114.x","article-title":"Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of bacillus anthracis protective antigen.","volume":"47","author":"MJ Gubbins","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1021\/bm060210p","article-title":"Synthesis of polyvalent inhibitors of controlled molecular weight: Structure-activity relationship for inhibitors of anthrax toxin.","volume":"7","author":"KV Gujraty","year":"2006","journal-title":"Biomacromolecules"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/IAI.00712-06","article-title":"Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.","volume":"74","author":"L Vitale","year":"2006","journal-title":"Infect Immun"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bmcl.2005.10.088","article-title":"The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.","volume":"16","author":"Y Xiong","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1586\/14787210.5.5.783","article-title":"Potential use of inhibitors of bacteria spore germination in the prophylactic treatment of anthrax and clostridium difficile-associated disease.","volume":"5","author":"Z Alvarez","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1128\/AAC.00741-07","article-title":"Treatment of experimental anthrax with recombinant capsule depolymerase.","volume":"52","author":"A Scorpio","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10930-008-9137-0","article-title":"A dual-purpose protein ligand for effective therapy and sensitive diagnosis of anthrax.","volume":"27","author":"M Vuyisich","year":"2008","journal-title":"Protein J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/17460913.4.1.35","article-title":"Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax.","volume":"4","author":"A Schneemann","year":"2009","journal-title":"Future Microbiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"13509","DOI":"10.1073\/pnas.0509870103","article-title":"Polyvalent inhibitors of anthrax toxin that target host receptors.","volume":"103","author":"S Basha","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"23349","DOI":"10.1074\/jbc.M401292200","article-title":"Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.","volume":"279","author":"DJ Wigelsworth","year":"2004","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays.","volume":"4(2)","author":"J Zhang","year":"1999","journal-title":"Journal of Biomolecular Screening"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1021\/jm030266r","article-title":"A specific mechanism of nonspecific inhibition.","volume":"46","author":"SL McGovern","year":"2003","journal-title":"J Med Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1535-7163.MCT-06-0242","article-title":"Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton.","volume":"5","author":"MN Bijman","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/AAC.01412-05","article-title":"Cisplatin inhibition of anthrax lethal toxin.","volume":"50","author":"M Moayeri","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref63","first-page":"3115","article-title":"Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)\/CXCR4 with antiangiogenic activity.","volume":"9","author":"X Chen","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/cbr.1999.14.135","article-title":"Tumor cell growth suppression by tannic acid.","volume":"14","author":"H Kamei","year":"1999","journal-title":"Cancer Biother Radiopharm"},{"key":"ref65","first-page":"2361","article-title":"Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice.","volume":"48","author":"H Mukhtar","year":"1988","journal-title":"Cancer Res"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.2910430321","article-title":"Protection against chemically induced skin tumorigenesis in SENCAR mice by tannic acid.","volume":"43","author":"M Das","year":"1989","journal-title":"Int J Cancer"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/cbr.1999.14.231","article-title":"Tannic acid raises survival rate of mice bearing syngeneic tumors.","volume":"14","author":"T Koide","year":"1999","journal-title":"Cancer Biother Radiopharm"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1053\/jhep.2003.50192","article-title":"Inhibition of cholangiocarcinoma growth by tannic acid.","volume":"37","author":"C Marienfeld","year":"2003","journal-title":"Hepatology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0039911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T23:11:48Z","timestamp":1642633908000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0039911"}},"subtitle":[],"editor":[{"given":"Rory Edward","family":"Morty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0039911","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}